Detalles de la búsqueda
1.
Epidemiology and O-Serotypes of Extraintestinal Pathogenic Escherichia coli Disease in Patients Undergoing Transrectal Ultrasound Prostate Biopsy: A Prospective Multicenter Study.
J Urol
; 205(3): 826-832, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079609
3.
A randomized phase 1/2a trial of ExPEC10V vaccine in adults with a history of UTI.
NPJ Vaccines
; 9(1): 106, 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38877036
4.
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.
Nat Med
; 12(1): 83-8, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16369542
5.
Safety, Reactogenicity, Immunogenicity, and Dose Selection of 10-Valent Extraintestinal Pathogenic Escherichia coli Bioconjugate Vaccine (VAC52416) in Adults Aged 60-85 Years in a Randomized, Multicenter, Interventional, First-in-Human, Phase 1/2a Study.
Open Forum Infect Dis
; 10(8): ofad417, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37608916
6.
Synergistic activity of ceftobiprole and vancomycin in a rat model of infective endocarditis caused by methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.
Antimicrob Agents Chemother
; 56(3): 1476-84, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22232278
7.
Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.
Antimicrob Agents Chemother
; 55(2): 836-44, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21135187
8.
Antistaphylococcal activities of the new fluoroquinolone JNJ-Q2.
Antimicrob Agents Chemother
; 55(12): 5512-21, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21911562
9.
In vivo activity of ceftobiprole in murine skin infections due to Staphylococcus aureus and Pseudomonas aeruginosa.
Antimicrob Agents Chemother
; 54(1): 116-25, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19884364
10.
Characterization of Escherichia coli isolates potentially covered by ExPEC4V and ExPEC10V, that were collected from post-transrectal ultrasound-guided prostate needle biopsy invasive urinary tract and bloodstream infections.
Vaccine
; 38(33): 5100-5104, 2020 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32561123
11.
In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Antimicrob Agents Chemother
; 53(5): 2028-33, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19273686
12.
Pharmacokinetic-pharmacodynamic modeling of the in vitro activities of oxazolidinone antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Antimicrob Agents Chemother
; 53(12): 5039-45, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19786607
13.
New agents in development for the treatment of bacterial infections.
Curr Opin Pharmacol
; 8(5): 582-92, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18761107
14.
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial.
Lancet Infect Dis
; 19(6): 631-640, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079947
15.
Safety, tolerability and immunogenicity of the ExPEC4V (JNJ-63871860) vaccine for prevention of invasive extraintestinal pathogenic Escherichia coli disease: A phase 1, randomized, double-blind, placebo-controlled study in healthy Japanese participants.
Hum Vaccin Immunother
; 14(9): 2150-2157, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29771596
16.
Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine.
Clin Vaccine Immunol
; 24(12)2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28971965
17.
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial.
Lancet Infect Dis
; 17(5): 528-537, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28238601
18.
Preparation of erythromycin analogs having functional groups at C-15.
J Antibiot (Tokyo)
; 59(7): 392-401, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17025015
19.
15-amido erythromycins: synthesis and in vitro activity of a new class of macrolide antibiotics.
J Antibiot (Tokyo)
; 58(3): 167-77, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15895524
20.
Novel antibacterial agents for the treatment of serious Gram-positive infections.
Expert Opin Investig Drugs
; 12(3): 379-99, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12605562